Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.7451
+0.0411 (5.84%)
At close: Jun 6, 2025, 4:00 PM
0.7301
-0.0150 (-2.01%)
After-hours: Jun 6, 2025, 6:35 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.75 million as of June 6, 2025. Its market cap has increased by 213.06% in one year.
Market Cap
4.75M
Enterprise Value
-4.97M
1-Year Change
213.06%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.75M, a decrease of -91.73%. That is a compound annual growth rate of -47.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 4.75M | 72.50% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.39% |
| Dec 30, 2022 | 4.95M | -65.84% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.72B |
| Johnson & Johnson | 374.36B |
| AbbVie | 335.40B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.81B |
| Abbott Laboratories | 234.67B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |